Home › Funds › Gryphon Financial Partners LLC › ABT

Gryphon Financial Partners LLC position in ABT

ABBOTT LABORATORIES · Health Care

Gryphon Financial Partners LLC reported holding 125,334 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$12.4M, representing 1.07% of its reported portfolio and ranking #17 among its reported holdings. Gryphon Financial Partners LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)125.33K sh
Reported value held$12.39M
Portfolio Weight1.07%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Gryphon Financial Partners LLC's ABT position evolved

Gryphon Financial Partners LLC first disclosed a stake in ABT in Q3 2023 at 107,409 shares (US$10.4M). The position peaked in Q2 2025 at 120,745 shares, worth US$16.4M. Across 13 filings, Gryphon Financial Partners LLC increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 125,334 shares valued at US$12.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 107.41K $10.40M New
Q4 2023 111.18K $12.25M Add
Q1 2024 111.43K $12.66M Hold
Q2 2024 113.62K $11.81M Add
Q3 2024 113.88K $12.98M Hold
Q4 2024 114.56K $12.96M Add
Q1 2025 115.24K $15.29M Add
Q2 2025 120.75K $16.42M Add
Q3 2025 118.64K $15.89M Reduce
Q4 2025 120.25K $15.07M Add
Q1 2026 121.87K $12.51M Add
Q2 2026 125.65K $11.40M Add
Q3 2026 125.33K $12.39M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Gryphon Financial Partners LLC held ABT?

Gryphon Financial Partners LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Gryphon Financial Partners LLC's current position in ABT?

As of Q3 2026, Gryphon Financial Partners LLC holds 125.33K shares of ABT (ABBOTT LABORATORIES), valued at $12.39M, representing 1.07% of its reported portfolio and ranking #17.

Has Gryphon Financial Partners LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Gryphon Financial Partners LLC held unchanged its position in ABT. The position peaked in Q2 2025 at 120.75K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.